对于中风后失眠的高压氧疗法:一个系统的审查和元分析协议
Rui Shi1, Wenyi Meng2, Zhaozheng Liu2
1Changchun University of Chinese Medicine, Changchun, Jilin, China.
BMJ open
|March 29, 2024
概括
这一系统性审查将评估高压氧气疗法 (HBOT) 对于中风后的失眠. 它的目的是澄清HBOT.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 心血管研究研究心血管研究
背景情况:
- 失眠是脑血管事件后的常见并发症,影响认知功能和恢复.
- 对于中风后失眠的高压氧疗法 (HBOT),现有的随机对照试验 (RCT) 尚未确定其益处或风险.
研究的目的:
- 系统地审查和分析RCT,以评估HBOT在中风后治疗失眠的疗效和安全性.
- 提供对HBOT在治疗中风后睡眠障碍中的作用的全面评估.
主要方法:
- 将对九个主要数据库进行系统的搜索,以查找关于中风后失眠的HBOT的RCT,并将在2023年11月1日之前以英语和中文出版.
- 两个独立审查员将选择研究,提取数据,并使用Cochrane协作工具评估质量.
- 将使用RevMan V.5.4和STATA V.16.0.b进行元分析,通过推,评估,开发和评估 (GRADE) 方法对证据质量进行评估.
主要成果:
- 主要结局:睡眠质量的变化.
- 二次结果:不良事件和复发率.
- 该审查将综合符合条件的RCT的数据,以确定治疗有效性和安全性.
结论:
- 这一系统性审查和元分析将提供关于HBOT治疗中风后失眠的有效性和安全性的关键见解.
- 结果将指导临床实践和未来的研究方向,关于对中风幸存者睡眠障碍的HBOT干预措施.
更多相关视频
相关概念视频
Management of Insomnia
244
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
244
Insomnia
85
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
85
CNS Depressants: Barbiturates and Benzodiazepines
259
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
259
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
206
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
206
Sedatives and Hypnotics Drugs: Miscellaneous Agents
171
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
171
Sedatives and Hypnotics: Overview
358
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
358


